Thomas Schmitt

@thomasm

19 Posts0 Followers1 Following

Thomas Schmitt@thomasm· Sunday at 6:27 PM

High-Performance Humanized Control Antibodies to Advance Infectious Disease Diagnostics

The main categories of infectious diseases include: 1) viral infections (e.g. SARS-CoV-2, influenza, HIV, dengue fever and hepatitis B and C); 2) bacterial infections (e.g. tuberculosis, salmonellosis and Lyme disease); 3) parasitic infections (e.g. malaria and leishmaniasis); 4) fungal infections (e.g. candidiasis and histoplasmosis); 5) prion diseases (e.g. Creutzfeldt-Jakob disease, fatal familial insomnia, Kuru and protease-sensitive prion diseases).<a href="https://www.creative-diagnostics.com/humanized-control-antibodies-for-infectious-disease-diagnostics.htm">Antibodies</a> are indispensable in diagnosing and treating diseases caused by pathogens and their toxins. Over a century ago, antibodies were first incorporated into the medical arsenal for combating infectious diseases by using animal sera to treat tetanus and diphtheria. Today, most therapeutic antibodies are developed primarily to target cancer or autoimmune diseases. The COVID-19 pandemic has once again highlighted the importance of antibodies in treating infectious diseases.Creative Diagnostics currently offers over 200 humanized control antibodies for infectious disease diagnostics, covering more than 50 clinically relevant pathogens, including viral, bacterial, parasitic, and fungal targets. These control antibodies are suitable for a wide range of applications, including the development and optimization of diagnostic assays, analytical and clinical validation studies, calibration and positive control materials, routine quality control in diagnostic laboratories, and diagnostic kit manufacturing and regulatory testing.Compared to traditional serum-derived controls, humanized control antibodies offer several advantages, including enabling serum-free production. Creative Diagnostics' antibodies are produced using a recombinant expression system and contain no animal-derived serum components. This approach reduces the risk of contamination, minimizes background interference and enhances reagent purity.Furthermore, recombinant antibody technology ensures precise control over antibody sequence and structure, thereby minimizing variation between batches. These antibodies exhibit long-term stability during storage and transport, ensuring consistent assay performance. Unlike human serum controls, recombinant antibodies can be produced consistently and on a large scale. This provides diagnostic kit manufacturers and clinical laboratories with a reliable supply chain.In addition, Creative Diagnostics' humanized control antibodies are compatible with a wide range of immunoassay technologies, including ELISA, CLIA and chemiluminescence platforms, as well as rapid diagnostic tests such as lateral flow assays. This product portfolio covers a wide range of infectious disease targets commonly used in clinical diagnostics, including viral pathogens such as HIV

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Advanced MERS-CoV Animal Models to Accelerate Coronavirus Vaccine and Drug Development

<a href="https://antiviral.creative-diagnostics.com/mers-cov-animal-model.html">MERS-CoV</a> is an emerging zoonotic virus that is considered to be one of the major public health threats. Since 2012, there have been consistent monthly cases of MERS-CoV causing severe respiratory illness, resulting in the death of approximately 35% of confirmed patients. It is believed that the virus is transmitted from camels in Middle Eastern countries through contact between humans and animals. The viral genome structure provides crucial insights into its pathogenicity and associated virulence factors.However, recent studies indicate that our understanding of the development of novel therapeutic strategies aimed at inducing antiviral immunity remains limited. The severity of MERS-CoV infection underscores the urgent need for effective therapeutic approaches. The ongoing threat to global public health posed by MERS-CoV, coupled with the need for novel therapeutic strategies, has driven the development of animal models that can reliably reproduce MERS-CoV-associated pathology in human infections.With extensive expertise and cutting-edge resources, Creative Diagnostics is committed to providing reliable animal models for MERS-CoV infection. This enables clients worldwide to gain a deeper understanding of the virus's complex mechanisms. Backed by a dedication to scientific excellence, these models show great promise in advancing research into the intricate pathogenesis of MERS-CoV, assessing potential therapeutic interventions and accelerating the development of effective strategies to combat this potent virus.Creative Diagnostics' MERS-CoV animal models primarily include the MERS-CoV Virus Tracheal Intubation Infection Rhesus Monkey Model, and the MERS-CoV Virus Intranasal Infection Mouse Model. By addressing key conditions such as mortality rates associated with severe respiratory disease, the absence of neurological complications at high viral loads and sustained high levels of viral replication in the lungs, Creative Diagnostics' animal models simulate human infection with MERS-CoV. They retain the innate expression of the MERS-CoV host receptor DPP4 and feature genetically modifiable host genes, making them suitable for vaccine and therapeutic response studies.Creative Diagnostics' animal models provide researchers with a controlled experimental platform on which to study viral behaviour, transmission, immune responses, and potential therapeutic approaches. Creative Diagnostics also offers a range of services to support MERS-CoV animal model research, including pathological analysis, immune response profiling, vaccine and antiviral compound efficacy testing, and data analysis and interpretation.Creative Diagnostics will be showcasing these preclinical services, alongside their comprehensive suite of viral and bacteri

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Highly Sensitive T7 RNA Polymerase ELISA Kits for Biopharmaceutical Impurity Detection

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the release of its new, highly sensitive and specific <a href="https://www.creative-diagnostics.com/t7-rna-polymerase-elisa-kit-item-deians032-117033.html">T7 RNA Polymerase ELISA Kits</a> for the detection and quantitative determination of T7 RNA Polymerase in biopharmaceutical samples. These kits provide a critical tool for researchers and manufacturers to monitor and control process-related impurities, ensuring the safety and efficacy of biologic drug products.Biopharmaceuticals are a class of drugs that are usually produced in living organisms and can be used to treat a wide range of diseases. Biopharmaceutical samples include hormones, enzymes, monoclonal antibodies, vaccines, and blood factors, each of which face different challenges during drug development and production, one of which is the presence and level of process-related impurities in the final biopharmaceutical product. Process-related impurities are any chemical substances or biological entities that are expected to be present during the manufacturing process, not completely removed during purification, or not expected to be present in the API or final drug product.Process-related impurities can be divided into three categories: first, cell substrate-derived impurities (e.g., proteins/nucleic acids from the host organism, such as host cell DNA); second, cell culture-derived impurities (e.g., inducers, antibiotics, serum and other media components); and third, downstream impurities (e.g., enzymes, chemical and biochemical processing reagents, like cyanogen bromide, reducing agents, inorganic salts, and solvents).Effective removal of process-related impurities or process residues is important for pharmaceutical and biopharmaceutical development. To meet the requirements of the ICH Q6B guidelines for the monitoring and controlling of process-related impurities and contaminants in biomanufacturing processes, Creative Diagnostics has developed a series of highly sensitive ELISA kits for the analysis of impurity residues. These kits are critical for cell substrate-derived impurities, cell culture-derived impurities and downstream impurities, supporting all phases of biopharmaceutical manufacturing.The new T7 RNA Polymerase ELISA Kit (DEIANS032) is specifically designed for the detection and quantitative determination of T7 RNA Polymerase, an enzyme commonly used in various bioprocessing applications. The kit uses a double antibody sandwich ELISA method and is highly sensitive with a lower limit of detection (LOD) of 0.1 ng/mL and a lower limit of quantitation (LOQ) of 0.25 ng/mL. In addition, the kit is highly specific with minimal cross reactivity (less than 0.1% with other antibiotics). Its robust design ensures high reproducibility with low within- and between-batch v

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Influenza Antiviral Drug Discovery with Comprehensive Screening and Evaluation Services

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced its comprehensive suite of services for <a href="https://antiviral.creative-diagnostics.com/screening-and-evaluation-of-anti-influenza-virus-antivirals.html">Influenza Antiviral Drug Screening and Evaluation</a>. Equipped with advanced technology platforms and a wide range of cell and animal models, the company now offers robust solutions to accelerate the discovery and development of novel antiviral therapies to combat influenza infections.Influenza is a major infectious disease that affects human life and health and places a heavy burden on the global economy and public health. Anti-influenza drugs are a class of medicines that fight influenza virus infection and relieve symptoms. They work in various ways to inhibit the growth and replication of the virus, thereby reducing the severity of illness and speeding recovery. Common anti-influenza drugs include oseltamivir, zanamivir, and aluminum hydroxide. These medications are usually used at the beginning of a viral infection for optimal antiviral effect.It should be noted that anti-influenza viral drugs cannot completely cure influenza, but they can reduce symptoms and shorten the duration of illness, especially in susceptible groups such as the elderly, children and pregnant women, and are of great clinical value. Existing marketed drugs have relatively limited therapeutic effects in patients with severe influenza and highly pathogenic avian influenza. Therefore, there is an urgent need to develop new drugs with novel mechanisms of action to meet the urgent clinical needs of influenza patients.Creative Diagnostics addresses this critical need by providing integrated services that span the drug discovery and development pipeline. Creative Diagnostics takes a multi-pronged approach to the screening and evaluation of anti-influenza compounds using a number of state-of-the-art technology platforms. These platforms include robust cellular assays, sophisticated immunological assays and precise molecular biology techniques. The company's screening capabilities are further enhanced by the use of a variety of relevant cell models, including Madin-Darby Canine Kidney (MDCK) cells, Immortalized Lung cells (A549 and Calu-3), and Human Colon Adeno-Carcinoma cells (CACO-2).In addition to in vitro studies, Creative Diagnostics utilizes a variety of animal models, including mice, ferrets, guinea pigs and swine, as well as alternative models such as yeast, Drosophila and zebrafish, to provide a more comprehensive understanding of drug efficacy and safety.The company's screening and evaluation efforts target a range of influenza virus types (Influenza A, B, and C) and key viral targets. These include neuraminidase inhibitors, M2 ion channel inhibitors, RNA polymer

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Enhanced Viral Nucleic Acid Residue Assay Kits for Biopharmaceutical Manufacturing

Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new Viral Nucleic Acid Residue Assay Kits (<a href="https://qbd.creative-diagnostics.com/products/viral-nucleic-acid-residue-assay-kits-qpcr-2793.html">qPCR</a>) to ensure the purity and safety of biopharmaceutical products by detecting and quantifying even minute levels of viral DNA and RNA contaminants. These kits can help manufacturers meet stringent regulatory requirements and quality control standards.Creative Diagnostics&rsquo; Viral Nucleic Acid Residue Assay Kits use state-of-the-art quantitative PCR (qPCR) technology that is highly sensitive and specific to reliably detect even trace amounts of viral nucleic acids. This capability is critical for maintaining the safety and efficacy of vaccines, gene therapies and other biological agents. In addition, these kits are designed to be easy to use, with reagents and detailed protocols for smooth integration into existing laboratory workflows.Creative Diagnostics is committed to providing innovative solutions that address the critical needs of the biopharmaceutical industry. By providing rapid and accurate results, these kits help manufacturers meet stringent regulatory requirements and maintain strict quality control standards. Viral nucleic acid residue test kits (qPCR) are essential to the biopharmaceutical industry as they effectively monitor for viral contamination, protecting product integrity and patient safety and ensuring the highest quality of advanced therapeutic products.For example, the ResDetFast&trade; E1A &amp; SV40LTA DNA Residual Assay Kit (Cat. No. DDNAF-027) targets conserved E1A and SV40LTA sequences, paired with a ready-to-use reference for rapid and sensitive detection of residual E1A and SV40LTA DNA in biological products derived from HEK293T cells. HEK293T, a common expression vector in biopharmaceutical production, carries transformation sequences like Adv E1A and SV40 large T antigen, posing potential safety risks. When used with Creative Diagnostics Nucleic Acid Extraction or Purification Kit, this kit can detect trace amounts of E1A &amp; SV40LTA DNA in as quickly as 1.5 hours, fulfilling regulatory requirements for sensitive detection of residual sequences in lentiviral vector preparations.Adeno-Associated Virus (AAV), a member of the Parvoviridae family, is a widely used gene therapy vector. rAAV, a modified version of wild-type AAV, can be contaminated with rcAAV, a replication-competent form resulting from non-homologous recombination during production. The ResDetFast&trade; rcAAV-2/N Assay Kit (Cat. No. DDNAF-008), a quantitative fluorescence PCR assay targeting the GALV gene, enables rapid and sensitive detection of rcAAV in gene therapy products. Paired with a quantitative reference and compatible with Creative

Thomas Schmitt@thomasm· Sunday at 6:27 PM

New Line of Diacetoxyscirpenol Test Reagents

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples, is proud to announce the development of a new series of high-quality test reagents for the detection of Diacetoxyscirpenol (<a href="https://www.creative-diagnostics.com/food-analysis/diacetoxyscirpenol.html">DAS</a>), a potent mycotoxin. These cutting-edge reagents are designed to enhance food safety and quality control measures.Diacetoxyscirpenol (DAS), also known as anguidine, is a type A monotrichothecene mycotoxin. It is a secondary metabolite of fungi of the genus Fusarium and is a major contaminant of cereals and cereal-based foods, potentially causing poisoning in farm animals. DAS has been detected in agricultural products worldwide and remains in products after processing. Studies have shown that consumption of diacetoxyscirpenol induces haematological disorders (neutropenia, aplastic anaemia) in humans and animals. The main adverse reaction following acute and repeated exposure to diacetoxycipranol is vomiting.In addition, DAS can cause many chronic and acute effects in animals and humans, such as immunotoxicity, haematotoxicity, pulmonary disease, growth retardation and cardiovascular effects. It can also damage a variety of organs and tissues, including liver, thymus tissue, brain, seminiferous tubules and epididymis. Additionally, DAS can inhibit the synthesis of proteins and DNA, resulting in oral lesions, decreased feed intake, lower serum iron-binding capacity, gastrointestinal lesions and diarrhoea in in various species including pigs, chickens, rabbits, rats, dogs, and calves.In 2016, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated the toxicity of DAS and decided to include DAS in the provisional tolerable daily intake (PTDI) group (WHO/FAO, 2002). To support the accurate and efficient detection of DAS and improve food safety and quality control, Creative Diagnostics now offers a range of sensitive and specific reagents for DAS detection, including Diacetoxyscirpenol Antibodies &amp; Antigens, Diacetoxyscirpenol ELISA Kits, and Diacetoxyscirpenol Screen Tests. These reagents are essential components of enzyme-linked immunosorbent assays (ELISA) and lateral flow immunoassays (LFIA), providing rapid and accurate results.For example, the Diacetoxyscirpenol ELISA Kit (Cat. No DEIASL114) can be used for the quantitative analysis of the DAS in grains. The kit is a competitive enzyme-labeled immunoassay that measures DAS residues extracted from ground grain samples with a 70% methanol/water solution. In addition, the Mouse Anti-Diacetoxyscirpenol monoclonal antibody, clone DAS (CABT-L4607) can recognize the conjugated form of the small molecule. The specificity of the antibody is determined by ELISA using c

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Novel Animal Models for Zika Virus Research

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its <a href="https://antiviral.creative-diagnostics.com/zika-virus-animal-model.html">Zika Virus Animal Model</a> services for scientists to understand the complex mechanisms of Zika virus infection and develop effective countermeasures. These models are valuable tools in the research and development of vaccines and therapeutics against this emerging global health threat.Zika virus is an arbovirus belonging to the genus Flavivirus. It has been little studied in the past because it has been reported to cause only mild symptoms such as fever, joint pain, conjunctivitis and rash. But in 2015-2016, the Zika virus suddenly emerged in Brazil, the United States and Southeast Asia. It spread rapidly, causing cases of miscarriage, microcephaly in newborns and Guillain-Barr&eacute; syndrome. More worryingly, the Zika virus can be transmitted not only vertically by mosquitoes but also sexually and through blood transfusions.Due to the large outbreaks of ZIKA virus-associated disease, the World Health Organization declared ZIKA virus a public health emergency of international concern in early 2016, greatly accelerating the pace of global research into ZIKA virus. Several disease models of Zika virus infection have been established in mice and non-human primates (NHPs) and used for diagnostic, therapeutic and preclinical evaluation of Zika virus vaccines.As Zika virus is associated with severe neurological disease and in an effort to prevent and protect against this virus, Creative Diagnostics provides clients with a range of services to develop small and large Zika virus animal models to elucidate the pathogenesis of this emerging disease and to develop vaccines and therapeutic strategies. These ZIKA virus animal models include, but are not limited to, the ZIKV Mouse Pregnancy Model, the ZIKA AG129 Mouse Model and the ZIKA Rhesus Macaque Model.For example, mouse models are commonly used to study Zika virus infection due to their genetic tractability and ease of handling, and Creative Diagnostics has been at the forefront of developing and providing high-quality mouse models for Zika virus research. These models allow scientists to study viral replication, tissue tropism and immune responses.In addition, rhesus monkeys have proven their value in bridging the gap between mouse models and human infection. These models are very similar to humans in terms of physiology, immune response and neurodevelopment, and the NHP model developed by Creative Diagnostics is helping to study Zika virus infection and its effects on neurodevelopment.Creative Diagnostics provides reliable animal models for researchers to study the pathogenesis, transmission, and prevention of Zika virus infection. By prov

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Bacterial DNA Residue Assay Kits (qPCR) for Biological Research

Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new&nbsp;<a href="https://qbd.creative-diagnostics.com/products/bacterial-dna-residue-assay-kits-qpcr-2792.html" target="_blank" rel="nofollow noopener">Bacterial DNA Residue Assay Kits</a>&nbsp;(qPCR) for researchers to detect and quantify trace amounts of bacterial DNA contamination in a wide range of biopharmaceutical products, ensuring the highest standards of safety and quality.Bacterial DNA residue assay kits (qPCR) are essential for maintaining the highest levels of product integrity and compliance in the biopharmaceutical industry. As an expert in bioprocess impurity analysis, Creative Diagnostics offers a range of Bacterial DNA Residue (qPCR) assay kits for the detection of trace levels of bacterial DNA contamination in biopharmaceutical products. By effectively monitoring for bacterial DNA contamination, these assay kits prevent potential adverse effects and ensure that the final product is safe for human use.These kits use advanced quantitative PCR (qPCR) technology with high sensitivity and specificity to reliably identify and quantify bacterial DNA residues. This is essential to ensure the safety and efficacy of biologics, vaccines and other pharmaceuticals. In addition, each kit comes with pre-optimized reagents and comprehensive instructions for seamless integration into existing laboratory protocols. The rapid and accurate results provided by these kits help manufacturers meet stringent regulatory standards and maintain strict quality control throughout the manufacturing process.For example, the E. coli DNA Residue Assay Kit (Cat. No. DDNA-021) uses PCR fluorescent probe technology to quantitatively detect residual E. coli DNA in samples. This kit provides rapid, highly specific and reliable detection with a minimum detection limit of fg levels. It contains a quantitative E. coli DNA reference standard and is used in conjunction with Creative Diagnostics Host Cell DNA Prep Kit to accurately determine the amount of residual E. coli DNA in biological samples.The routine testing method for mycobacteria, the culture method, is time-consuming and does not meet the testing requirements of short-life biological products. To address this limitation, the ResDetFast&trade; Mycobacterium DNA Assay Kit (Cat. No. DDNAF-002), a quantitative fluorescence PCR-based assay designed with primers and probes, targets conserved Mycobacterium sequences for rapid and qualitative detection of Mycobacterium DNA in various biological products, including intermediates, semi-finished and finished products. When used in conjunction with Creative Diagnostics Nucleic Acid Extraction or Purification Kit, this kit can detect Mycobacterium DNA at the 10 CFU level in as little as 1.5 hours.<p&g

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Novel Cyclopiazonic Acid Test Reagents

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples, is excited to announce the release of its&nbsp;<a href="https://www.creative-diagnostics.com/food-analysis/cyclopiazonic-acid.html" target="_blank" rel="nofollow noopener">Cyclopiazonic Acid Test Reagents</a>&nbsp;to help ensure food safety. These reagents are designed to support the development of sensitive and specific immunoassays for the detection of this mycotoxin in food and other matrices.Cyclopiazonic acid (CPA) is an indole trichothecene toxin produced by several species of Penicillium, mainly Penicillium camemberti, Penicillium chrysogenum, Penicillium commune, Penicillium viridicatum and Penicillium griseofulvum. Some Aspergillus species, such as Aspergillus flavus and Aspergillus oryzae, can also produce CPA. Several authors have identified peanuts as the main source of this toxin, but studies have also shown that the toxin is present in products such as cereals, prosciutto, cheese, fruit and other nuts.CPA is not acutely toxic, with an oral LD50 of 30-70 mg/kg in rodents. The main target of this toxin is the nervous system and it is therefore considered a neurotoxin. Ingestion of CPA results in signs of ataxia and, in extreme cases, death due to spastic paralysis. It can also cause gastrointestinal lesions. The effect of CPA exposure on cells is due to the inhibition of calcium channels in cells. The toxin is a potent and selective inhibitor of calcium ATPase activity.Cyclopiazonic acid appears to be toxic only at high concentrations. The symptoms associated to CPA consumption also include anorexia, dehydration, weight loss, immobility and, in the case of near death, convulsions. Few cases of mycotoxicosis with cyclopiazonic acid have been reported because the poisoning is benign, the amount of toxicity is small, and the effects may be masked by concurrent aflatoxin poisoning (some toxicity data may have been derived from the use of aflatoxin-contaminated CPA). To date, there are no national regulations on CPA levels in food products.Consumption of CPA-contaminated foods can pose health risks and it is therefore essential to monitor food products for the presence of this mycotoxin. Creative Diagnostics&rsquo; new Cyclopiazonic Acid test reagents are highly sensitive and specific and can be used with a variety of analytical methods including ELISA and LFIA. These reagents, such as Cyclopiazonic Acid Antibodies &amp; Antigens, Cyclopiazonic Acid ELISA Kits, and Cyclopiazonic Acid Screen Tests, are also easy to use and require minimal sample preparation.Creative Diagnostics is committed to providing high-quality research reagents and diagnostic solutions to support the development

Thomas Schmitt@thomasm· Sunday at 6:27 PM

MERS-CoV Animal Models to Support Antiviral Research

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is pleased to announce availability of its <a href="https://antiviral.creative-diagnostics.com/mers-cov-animal-model.html">MERS-CoV Animal Model</a>s to support antiviral research. These animal models are valuable tools to advance research into the complex pathogenesis of MERS-CoV, evaluate potential therapeutic interventions and accelerate the development of effective strategies to combat the virus.Viruses are a major threat to global health, causing a range of diseases from haemorrhagic fevers to neuroinvasive infections. To develop effective countermeasures, it&rsquo;s essential to understand the intricate mechanisms by which viruses infect and cause disease in humans. Animal models have been instrumental in advancing the knowledge of viral pathogenesis by facilitating the study of virulent strains in a controlled environment. These models allow researchers to monitor disease progression, evaluate vaccine efficacy and develop novel therapeutic interventions, ultimately improving our ability to control viral infections.MERS-CoV, the virus that causes Middle East Respiratory Syndrome (MERS), is a potent respiratory pathogen. Effective animal models are essential to facilitate the development of vaccines and treatments. With a wealth of knowledge and state-of-the-art resources, Creative Diagnostics is dedicated to providing reliable animal models of MERS-CoV infection to help customers around the world delve deeper into this complex virus. These models simulate human MERS-CoV infection by addressing key conditions, such as reproducibility, mortality associated with severe respiratory disease, absence of neurological complications from high viral loads, and sustained high viral replication in lungs.Bridging the gap between in vitro and clinical studies, these animal models provide researchers with a controlled experimental platform to study virus behavior, transmission, immune responses, and potential treatments. Specifically, Creative Diagnostics provides MERS-CoV Virus Tracheal Intubation Infection Rhesus Monkey Model and MERS-CoV Virus Intranasal Infection Mouse Model, offering valuable insights into disease mechanisms. In addition, Creative Diagnostics offers a comprehensive range of services to support MERS-CoV animal model studies, including study design and execution, pathological analysis and immune response profiling, efficacy testing of vaccines and antiviral compounds, and data analysis and interpretation.These new animal models hold immense promise for advancing research on the intricate pathogenesis of MERS-CoV, evaluating potential therapeutic interventions, and accelerating the development of effective strategies to combat this dreaded virus. By utilizing these advanced tools, researchers can evaluate Coronavirus vaccine c

Thomas Schmitt@thomasm· Sunday at 6:27 PM

High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its highly specific <a href="https://www.creative-diagnostics.com/Anti-Adenovirus-hexon-protein-MAb-FITC-Conjugated-129647-491.htm">Anti-Adenovirus Monoclonal Antibody</a>. This research tool offers exceptional accuracy and sensitivity for the detection of adenoviruses in various applications such as IF, ICC, and ELISA.Adenoviruses (members of the family Adenoviridae) are medium-sized (90-100 nm), nonenveloped viruses with icosahedral nucleocapsids containing a double-stranded DNA genome. The name derives from the first isolation of an adenovirus from human adenoids in 1953. Adenoviruses DNA viruses are generally widespread in nature with a variety of vertebrate hosts. In humans, 88 human adenoviruses have been identified in seven populations (A through G) and more than 50 different adenovirus serotypes have been identified, causing a wide range of diseases from mild respiratory infections in young children to life-threatening multi-organ disease in people with compromised immune systems.Culture is the gold standard for diagnosis of adenovirus infection. However, culture results can take up to 3 weeks. Serological tests have a faster turnaround time but may not be as sensitive as culture. Because of the clinical importance of rapid laboratory diagnosis, direct detection of viral antigens in nasopharyngeal secretions, feces, or both is used as the primary diagnostic test for adenovirus infection.Immunofluorescence (IF) was the first method used for rapid diagnosis of respiratory infections caused by viruses. In the hands of an experienced microscopist, the method is both sensitive and specific. Individual specimens can be tested on arrival at the laboratory and results are available within a few hours. The most important aspect of IF is specimen collection and processing, and a sufficient number of infected respiratory epithelial cells should be obtained.Adenoviruses are a common cause of respiratory illness, and effective research tools are crucial for understanding and developing treatments for these infections. Recognizing the importance of accurate diagnosis of adenoviruses for effective treatment and to support the adenovirus research, Creative Diagnostics now offers new Anti-Adenovirus Monoclonal Antibodies to help researchers to identify and study these viruses. In addition, Creative Diagnostics offers qualitative or quantitative ELISA kits for the detection of ADV antibodies in serum or plasma.Creative Diagnostics provides Anti-Adenovirus Monoclonal Antibody in various formats and quantities to meet specific research needs. These highly specific antibodies target the hexon protein of adenoviruses, making them a valuable tool for researchers studying these common pathogens. Addi

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Reliable Hemagglutination Assay for Virus and Antibody Detection

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its Hemagglutination Assay (<a href="https://antiviral.creative-diagnostics.com/hemagglutination-assay-ha.html">HA</a>) services for effective virus and antibody detection. The new anti-virus testing solution offers a valuable tool for researchers working on influenza virus characterization, vaccine development, and general viral diagnostics.Certain viruses agglutinate red blood cells in certain animals, a process known as viral hemagglutination. HA test is designed to infer the presence of the virus in the material being tested and to determine whether this response is specific. It is a well-established method that is widely used in influenza vaccine, diagnostic and surveillance to measure virus and antibody titers and to monitor influenza subtypes.Hemagglutination occurs when the hemagglutinin protein on the surface of the influenza virus binds to a serine on red blood cells (RBCs). Similarly, when sufficient numbers of virus and RBCs are present, the virus particles act as a bridging agent, forming a network that connects the RBCs, resulting in hemocoagulation.The hemagglutination assay is the most commonly used method for detecting influenza virus, adenovirus, rabies virus, and many other microorganisms. It is the basis for a wide range of veterinary and life science diagnostic tests. HA analysis is simple, uses relatively inexpensive and commonly available instruments and consumables, and provides results within a few hours. The method has been well validated in many laboratories around the world and has a degree of reliability, comparability and standardization.In addition, the ability of viruses to agglutinate RBCs can be inhibited by specific antibodies, leading to the development of the hemagglutination inhibition (HAI) assay. The HA-HAI test allows the identification of unknown viruses in known sera and the titration of antibodies in unknown sera with known viruses by determining the level of the corresponding antibodies. The hemagglutination assay, used in conjunction with interactions, produces a visible network showing the relative concentrations of viruses and antiviral antibodies.Creative Diagnostics now offers Hemagglutination Assay services and customized early detection solutions to life science researchers focused on antiviral and infectious disease diagnostics. The research team combines infectious disease and analytical expertise to provide customers with the most powerful portfolio of antiviral and antimicrobial in vitro testing services.For example, the Creative Diagnostics team uses a wide range of erythrocytes from different species (chicken, guinea pig, goose, horse, cow, sheep, rabbit, and human A, B, AB, and O) and standardizes experiments u

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Patulin Test Reagents for Food Safety Applications

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, announces the availability of its high-quality <a href="https://www.creative-diagnostics.com/food-analysis/tag-patulin-37.htm">Patulin Test Reagents</a>. These reagents are suitable for assisting food producers and regulatory agencies in ensuring the safety of apples and apple-derived products.Patulin is a secondary metabolite of certain fungi of the genera Penicillium, Aspergillus and Batrachytrium, but more specifically Penicillium expansum appears to be the fungus that produces patulin. It is a common contaminant of apples, and levels of patulin in apple products are often used as a measure of apple quality in food production. Patulin can be found in apple juice, apple sauce, apple puree, baby food and cider. It has also been found in other foods such as cereals, fruits and vegetables.Patulin has been found to cause a variety of health problems in laboratory animals. There is concern that humans may be similarly affected and exposure should be minimized. Legal limits vary from country to country, and the World Health Organization recommends a maximum concentration of 50 &micro;g/L in apple juice. In the European Union, the limit is set at 50 micrograms per kilogram (&micro;g/kg) for both apple juice and cider, and at half that concentration, 25 &micro;g/kg, for solid apple products and 10 &micro;g/kg for products for infants and young children.Creative Diagnostics is committed to providing high-quality testing solutions to help protect consumers from the potential health risks associated with Patulin contamination. The company now offers a comprehensive portfolio of Patulin Test Reagents for food safety applications, including Patulin ELISA Kit, Patulin Standard (95%), and Anti-Patulin Polyclonal Antibody. For example, the Patulin ELISA Kit (Catalog# DEIANJ49) is a direct competitive ELISA based on the recognition of Patulin by specific antibodies.Creative Diagnostics Patulin Test Reagents provide food manufacturers with a reliable and accurate method for detecting Patulin in apple juice, applesauce, baby food and other apple products. By utilizing Creative Diagnostics&rsquo; Patulin Test Reagents, food manufacturers can ensure their products meet the highest safety standards. For example, they can monitor the quality of their apples and make sure their products comply with food safety regulations. Most importantly, early detection of patulin contamination helps prevent contaminated products from reaching consumers.Creative Diagnostics is dedicated to providing quality reagents for safeguarding food quality and protecting public health. These highly specific Patulin Test Reagents offer scientists a valuable and

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Ochratoxin Test Reagents for Enhanced Food Safety Analysis

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, announced the launch of its comprehensive portfolio of <a href="https://www.creative-diagnostics.com/food-analysis/tag-ochratoxin-36.htm">Ochratoxin Test Reagents</a>. These reagents are specifically designed to aid in the accurate detection of ochratoxin A (OTA) in food products.OTA is a para-chlorophenolic mycotoxin produced by molds of the genera Aspergillus and Penicillium. It is the most abundant and relevant mycotoxin of this group, while ochratoxins B and C are of lesser importance. This mold toxin is extremely harmful to human and animal health. Dietary exposure to ochratoxins can cause acute nephrotoxicity in mammals. In addition to its apparent nephrotoxicity, ochratoxin A has hepatotoxic, teratogenic, carcinogenic and immunosuppressive properties.The main sources of ochratoxin are cereals, including barley, rye, wheat, corn, sorghum and oats. It is also found in commodities such as coffee beans, dried fruits and grapes, including wine and raisins. In addition, meat and meat products may be contaminated with this toxin. Regulations on OTA limits vary from country to country. Typical limits are 5 &micro;g/kg for unprocessed cereals, 2 &micro;g/kg for wine and 0.5 &micro;g/kg for infant formula.Ochratoxin A is of particular concern because it may be a human carcinogen, making its detection especially important. Recognizing the importance of accurate and reliable testing methods to ensure the safety of food products, Creative Diagnostics now offers a wide range of reagent products to assist in the accurate detection of ochratoxin, including Ochratoxin Immunoaffinity Columns, Ochratoxin ELISA Kits, Anti-Ochratoxin Monoclonal Antibodies.Based on advanced detection technologies, these new Ochratoxin Test Reagents enable accurate detection of ochratoxin levels in a range of food samples, including grains, feedstuff, and processed foods, providing high sensitivity and specificity. For example, the Ochratoxin A Colloidal Gold Kit, a lateral flow immunoassay, can be used to detect ochratoxin A in grain and feed.The new Ochratoxin Test Reagents are designed to assist food safety professionals in meeting their strict quality control standards. They are suitable for use in various testing applications and allow food safety professionals to choose the most appropriate testing method based on their specific needs and requirements. Creative Diagnostics remains committed to providing cutting-edge solutions for food safety testing. The launch of these new Ochratoxin Test Reagents shows the company&rsquo;s dedication to ensuring the safety and quality of food products.The new Ochratoxin Test Reagents from Cre

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Plaque Reduction Assay Services to Advance Antiviral Research

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive suite of <a href="https://antiviral.creative-diagnostics.com/plaque-reduction-assays.html">Plaque Reduction Assay</a> services to support antiviral research. These new solutions offer researchers a powerful and well-established method for evaluating the efficacy of antiviral compounds.Normal cells can absorb reactive dyes during metabolism, but when the cells are infected with a virus, they lose their ability to absorb the dye, resulting in the formation of colorless plaques. When a virus is neutralized by a specific antibody and then infects a cell, the number of cellular plaques formed decreases accordingly. Therefore, the titer of the antibody that neutralizes the virus can be calculated from the number of cellular plaques.The Plaque Reduction Assay measures the efficiency with which the virus forms plaques in the presence of different concentrations of the assay. The time required for plaque visualization depends on the kinetics of viral replication and ranges from 24 hours to several weeks. Because plaques must be at least 1 mm wide to be accurately scored (especially by the naked eye), this analysis is typically performed on 24-well or 6-well plates, as any smaller wells may compromise readability and resolution.The plaque reduction neutralization test (PRNT) is a variant of the plaque reduction assay and is considered the gold standard for detecting neutralizing antibodies to certain viruses, such as dengue virus. The basic design of the PRNT is to generate virus-antibody interactions in test tubes or microtiter plates and then apply the mixture to virus-sensitive cells to measure the effect of the antibody on virus infectivity.PRNT is a versatile tool in virology with applications in diagnosing viral infections, characterizing toxins, and vaccine development. It can be used to detect antibodies in a patient&rsquo;s serum or identify viruses in diseased tissue, aiding in diagnosis. PRNT can also be utilized with antitoxin serum to identify and quantify bacterial toxins in pathological material. Furthermore, it is a valuable technique for determining the potency of antiviral serums and antitoxins, as well as identifying and classifying newly isolated viruses.As a solution provider for virology and microbiology research, Creative Diagnostics offers comprehensive Plaque Reduction Assay services (e.g., PRNT) to empower researchers to accelerate breakthroughs in the field of virology. The company is dedicated to providing antiviral testing and customized early detection solutions to life science companies working in the field of antiviral and infectious disease diagnosis.For viruses with only minor cellular lesions or viruses that take a long ti

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Norovirus VLP Antigens to Support Vaccine Research

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its new line of <a href="https://www.creative-diagnostics.com/new-norovirus-vlp-antigens.htm">Norovirus VLP Antigens</a> to accelerate in vitro diagnostics and vaccine research. These new antigens have been validated to a high level of confidence using electron microscopy.Norovirus is a non-enveloped, positive-sense, single-stranded RNA virus of the family Caliciviridae and is the leading cause of non-bacterial acute gastroenteritis worldwide. The infection is characterized by non-bloody diarrhea, vomiting and abdominal pain. The stability of viral particles is of particular interest because noroviruses are transmitted by the fecal-oral route and they can persist in the environment. Studies of the assembly and degradation of norovirus capsids have relied heavily on norovirus-like particles.The norovirus genome is 7.4-7.7 kb in size and has three open reading frames (ORFs). Nonstructural proteins, such as RNA-dependent polymerase (RdRp), are encoded by ORF1, while structural proteins are encoded by ORF2 (VP1) and ORF3 (VP2). Structural analysis of noroviruses has shown that each viral capsule consists of 90 dimers of VP1 with T = 3 icosahedral symmetry. Various expression systems have been developed to produce viral capsids in the form of virus-like particles (VLPs).Noroviruses are classified into genomic groups and genotypes based on the amino acid diversity of the VP1 protein. According to this system, the genus Norovirus is divided into 10 genomes (GI-GX) and 49 genotypes (9 GI, 27 GII, 3 GIII, 2 GIV, 2 GV, 2 GVI, and 1 each of GVII, GVIII, GIX [formerly GII.15 ], and GX), of which the genomes known to be infectious to humans include GI, GII, GVIII, and GIX. GII.4 is of particular importance as it has caused numerous outbreaks worldwide over the years and is believed to be the primary cause of human infections.Creative Diagnostics now offers a series of yeast-expressed Norovirus VLP antigens for in vitro diagnostic and vaccine studies, including Recombinant Norovirus GI.1 VLP, Recombinant Norovirus GII.3 VLP, and Recombinant Norovirus GII.17 VLP. These antigens have been validated with high confidence by electron microscopy and provide researchers and diagnosticians with a powerful tool for studying and detecting Norovirus infections. Creative Diagnostics&rsquo; team of experts is also available to assist researchers in selecting the most suitable antigens for their specific studies.The purified Norovirus VLP Antigens are an example of Creative Diagnostics' commitment to providing innovative and reliable products to the research and diagnostic communities. Its team has worked diligently to develop antigens that are not only highly specific but also offer excellent sensitivi

Thomas Schmitt@thomasm· Sunday at 6:27 PM

High-Affinity Anti Venom Antibodies for Research Applications

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its high-affinity&nbsp;<a href="https://www.creative-diagnostics.com/anti-venom-polyclonal-antibody.htm" target="_blank" rel="nofollow noopener">Anti Venom Antibodies</a>&nbsp;to researchers studying snakebite envenomation. These antibodies hold immense potential for improved snakebite treatments.Snakebite envenomation is considered a neglected tropical disease that affects tens of thousands of people each year. Snake venom is an extremely complex mixture consisting mainly of proteins (&plusmn;90-95%), in addition to peptides, carbohydrates, fragments of nucleic acid derivatives, metal ions, biogenic amines, lipids and free amino acids, which have different biological activities.In general, viperid venoms are cytotoxic, hematotoxic, and occasionally myotoxic due to the fact that snake venom metalloproteinases (SVMPs) weaken capillaries and blood vessel walls, leading to hemorrhage. SVMPs and phospholipase A2 (PLA2) also cause tissue damage at the site of the bite, resulting in muscle weakness and tissue necrosis. On the other hand, elapid venoms (and a small percentage of viperid venoms) contains neurotoxins (which primarily cause systemic neurotoxicity) that block neuromuscular signaling. These toxins eventually block signaling to the lung muscles, causing respiratory paralysis and death.Currently, the recommended treatment for snakebite is the use of antivenom or serum therapy, which treats snakebite by neutralizing the venomous toxins produced by snake venom. The most important clinical determinants in the treatment of snakebite are the type of antivenom to be used and the dose of antivenom. The specificity and dosage of antivenom depend on the accurate diagnosis of the snake. This requires the use of immunology-based assays, such as ELISA, to detect and quantify specific venoms to confirm the identity of the snake. In addition, the free venom of the patient is measured after therapy to determine if sufficient antivenom has been administered. Immunoassays can also be used to evaluate the cross-reactivity of antivenoms.Effective antivenom therapy is critical to saving lives, but accurate diagnosis and appropriate antivenom selection are often challenging. Creative Diagnostics now offers a comprehensive portfolio of anti venom antibodies that target a broad range of toxins found in snake venom, providing researchers with valuable tools for the development of new and improved antivenom therapies. These new anti-venom polyclonal antibodies are specifically designed for research applications and are not intended for diagnostic use, such as the Sheep Anti-Vipera l atastei Venom PolyclonalAntibody (DPAB-JX2371341).Creative Diagnostics is committed to advanc

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Immunofluorescence Assay Testing Services for Virology Research

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is pleased to announce the launch of its state-of-the-art Immunofluorescence Assay (<a href="https://antiviral.creative-diagnostics.com/ifa-testing.html" target="_blank" rel="nofollow noopener">IFA</a>) Testing services to support virology research. The new services provide researchers with a critical tool to confirm the presence or absence of antibodies against specific viruses, commonly employed in an ELISA or MFIA test.The IFA is a standard technique in virology and is commonly used to confirm the presence of infectious antibodies to specific viral antigens. The technique is typically used after an enzyme-linked immunosorbent assay (ELISA) or multiple fluorescence immunoassay (MFIA) to confirm a positive result. Creative Diagnostics is committed to providing researchers with the most advanced technology and expertise to advance antiviral research. These new IFA testing services offer a cost-effective and reliable solution and unparalleled support in IFA development and application, helping researchers accelerate their antiviral programs.Specifically, in the first incubation step, specific antibodies in the diluted sample bind to the solid-bound antigen. In the next step, a fluorescein-labeled antibody (conjugate) binds to the specific antibody in the sample. The complex is clearly visible under a fluorescence microscope when excited at the appropriate wavelength. Test processing can be manual, semi-automated, or fully automated.Creative Diagnostics&rsquo; IFA testing services offer several advantages. They are relatively inexpensive to perform, and the morphology and location of the fluorescence can be evaluated to distinguish specific from non-specific reactions. Additionally, these assays are validated with a panel of titered sera to ensure sensitivity, and they allow the detection of IgG or IgM antibodies. Finally, the presence of positive and negative control cells provides a built-in check for the accuracy of the test. These IFA testing services offer a powerful combination of experience, flexibility, and accuracy to accelerate critical research efforts.In addition, Creative Diagnostics has a team of experienced scientists who are experts in IFA development and understand the importance of accurate and reliable IFA tests. By combining its IFA testing expertise with its in-depth knowledge of antiviral research, Creative Diagnostics is dedicated to working closely with clients to develop assays that meet their specific needs.Utilizing cutting-edge technology, Creative Diagnostics offers a wide range of antiviral services to evaluate the inhibitory activity of inhibitor candidates. Moreover, a variety of customized antiviral assays are available to elucidate the action mechanism of novel antiv

Thomas Schmitt@thomasm· Sunday at 6:27 PM

Comprehensive Fumonisin Test Reagents for Precise Food Safety Analysis

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, announced the launch of its comprehensive line of&nbsp;<a href="https://www.creative-diagnostics.com/food-analysis/tag-fumonisin-35.htm" target="_blank" rel="nofollow noopener">Fumonisin Test Reagents</a>, including conjugates, antibodies and test kits. These new reagents offer reliable and accurate solutions for detecting the harmful mycotoxin, fumonisin, in various food and grain products.Fumonisins are mycotoxins produced by several Fusarium species, including Fusarium verticillioides and Fusarium proliferatum. These compounds are inhibitors of ceramide synthetase, preventing membrane biosynthesis. In humans, fumonisins have been linked to esophageal cancer. For animals, including horses, pigs, poultry, and cattle, fumonisins can cause heart and liver damage, growth retardation, and kidney and liver cancer. Like other mycotoxins, fumonisins harm animals and humans through the food, feed and pet food supply chain. Corn and small grains such as wheat, oats and barley are the main crops affected.Exposure to fumonisin can cause a variety of health problems in humans and animals, thus the detection of this mycotoxin is of critical importance and requires reliable analytical methods. Creative Diagnostics is committed to developing quality assays to support the development of mycotoxin detection. After years of research by its technical staff, Creative Diagnostics has successfully developed a range of antigens and antibodies for immunoassays and established enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA) detection platforms.Creative Diagnostics now offers a variety of Fumonisin Test Reagents to provide a reliable and sensitive method for detecting fumonisin in food and grain products, helping to ensure the safety of the food supply. These new Fumonisin Test Reagents are designed for use in a variety of analytical techniques, including ELISA, HPLC, and PCR. The company also offers a variety of other mycotoxin test kits and custom assay development services to meet the specific needs of its customers.For example, the Fumonisin B1 Test (DTS437) is a competitive immunoassay for the semi-quantitative detection of Fumonisin B1 in grain or feed. The kit can be stored at room temperature (2-30&deg;C) and is stable until the expiration date (18 months) marked on the foil pouch. In addition, the Fumonisin Plate Kit (DEIA6848) can be used for the quantitative analysis of fumonisin in corn, corn meal, corn germ meal, corn gluten meal, and corn/soy blend. These Fumonisin Test Reagents are easy to use and can be performed in a variety of laboratory settings.Creative Diagnostics offers a comprehe